WINCHESTER, UK — Exosect announced two new appointments. David Richardson joins Exosect as financial director. With more than 20 years financial experience, a qualified accountant and treasurer, Richardson’s experience has been focused in the bio-technology sector working for companies such as Evotec AG, Zeneca Cellmark Diagnostics and Marlow Foods then part of ICI Biological Products.
Peter Keen was recently appointed as Exosect’s new non-executive chairman. Keen is a chartered accountant and brings with him over 25 years experience in financing and management of companies within the emerging bio-technology and pharmaceuticals sectors.
Keen is currently a non executive director of Ark Therapeutics Groups PLC, Biotechnology Growth Trust plc (“BGT) and Abcam plc which he joined prior to the companies’ IPO. He is also the Non Executive Director of Serentis Ltd. Previously he was the CFO at Arakis until its successful trade sale in 2005.
Latest from Pest Control Technology
- How to Take Advantage of Networking in the Pest Control Industry
- Rat Damage to Vehicles Rises as Temperatures Grow Colder
- CSI: Termites
- Drowning in the Details? Seven Steps to Overcoming the Urge to Micromanage
- Ground Dove Population Increases on Ulong Island Following Removal of Invasive Rats
- Miller Pest Solutions Promotes Keith Johnson to External Operations Director
- Anticimex Carolinas Family of Brands Sponsors Salvation Army Angel Tree Program
- Guest Feature: Insight Canada’s Path to Sustainable Success in Quebec
